Skip to main content
Home

Main Menu

  • All News
    • Press Releases
  • Media Library
  • Company Info
    • We Are Vertex
    • Leadership
    • Virtual Lab Tour

Menu Subscribe

  • Subscribe

Main Menu

  • All News
    • Press Releases
  • Media Library
  • Company Info
    • We Are Vertex
    • Leadership
    • Virtual Lab Tour

Nav Share - Mobile

  • Linkedin icon
  • Twitter icon
  • Youtube icon

Menu Subscribe

  • Subscribe
  1. NEWSROOM HOME

All News

August 23, 2019 9:27 pm

All News

View
Press Release | May 02, 2022
Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes
READ MORE
Press Release | April 21, 2022
Vertex to Announce First Quarter 2022 Financial Results on May 5
READ MORE
Press Release | April 20, 2022
Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 Through 11 years With At Least One F508del Mutation
READ MORE
Press Release | March 31, 2022
Vertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept Studies of VX-548 for the Treatment of Acute Pain
READ MORE

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Current page 2
  • Page 3
  • Next page Next

Sign Up for Updates

  • Subscribe

Media Inquiries

E-mail: mediainfo@vrtx.com 
Phone:
+1 617-341-6992
(North America)
+44 20 3204 5275
(UK, Europe & Australia)

Related Links

  • Investors
  • Media Library

Subscribe for Updates

Email Updates

You may sign up to receive our news releases via email. The release will come to your email as body text within the message. You may unsubscribe by using the link at the end of each release you receive via email.

 

Connect With Us

Follow Vertex on Twitter
Subscribe to the Vertex YouTube channel
Follow Vertex on Facebook
Connect with Vertex on Linkedin
Follow Vertex on Instagram

The Science of possibility

  • The Science of Possibility
    Long Description

    Vertex creates new possibilities in medicine to cure diseases and improve people's lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.

  • Locations
    Long Description

    Corporate Headquarters
    50 Northern Avenue
    Boston, MA 02210
    Tel +1(617)-341-6100

    Child Links
    Global Locations
  • Newsroom
    Child Links
    All News
    Company Info

Footer menu

  • Privacy
  • Terms of use
  • Compliance program
  • Transparency

Social Share

  • Linkedin
    Icon
    LinkedIn logo
  • Twitter
    Icon
    Twitter logo
  • YouTube
    Icon
    YouTube logo

Vertex and the Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated.

© 2022 Vertex Pharmaceuticals Incorporated